3/10 · Low — ~11% forward adj-EPS CAGR, mid-to-high-single-digit organic revenue, decelerating; a mature oligopoly, not a fast compounder
Technicals
Consolidating — $439.89, −22% off 52-wk high, above 50-DMA but below 200-DMA, RSI 69, −16.9% 12-mo (SPY +20.6%)
Conviction
Moderate — 0 expert voices in the Synthos KB; call rests entirely on fundamentals, valuation and quant
Position sizing
Core-defensive if bought, ~2–4% — a quality holding, not a high-conviction overweight
Next catalyst
2026-07-30 Q2'26 earnings (Street adj-EPS $4.92)
Single biggest risk
Ratings is tied to debt-issuance volumes — a credit/issuance freeze compresses the highest-margin segment
One-line thesis. SPGI is one of the best businesses in the S&P 500 — a toll-booth oligopoly (Ratings + Indices) throwing off 70% gross and 44% EBIT margins with ~$5.5B of free cash flow — that has quietly de-rated ~22% off its high as debt-issuance and FX tailwinds cooled; at ~23× forward adjusted EPS with a Mobility spin unlocking value, the risk/reward is favorable for a patient owner, but the growth is mid-single-digit organic and decelerating, so this is a buy-the-quality-on-weakness call, not a rocket.
◆ Synthos call — Buy — CoreSPGI is attractively priced but a top-tier compounder — own it now and add on dips toward the 50-day (~$411–$440).
Downside Risk (lower = safer)
4/10 · Moderate
Low leverage (net-debt/EBITDA 1.5×) & beta ~1.1, but 28× trailing and a -22% drawdown off the high show it de-rates when issuance slows.
Durable oligopoly compounder, not an exponential — high-single-digit revenue growth, decelerating, $130B cap and cyclical ratings tie caps the multibagger.
◆ Target entry zone$411 – $440accumulate in this band; ideal adds on a dip toward the 50-day average near $411, keeping roughly a 19% margin below our $545 base-case fair value⚖ Reverse-DCF cross-checkMarket-implied growth ≈ 16%/yrTo justify today’s $440, earnings would have to compound roughly 16% a year for 10 years (9% discount rate). Analysts forecast ~15%/yr, so the market is pricing in about what the Street expects.What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.
Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.
WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.
HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.
AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.
In plain English
S&P Global is the company behind the S&P 500 index itself, and it is one of the two big firms (with Moody's) that grade how safe a company's or government's debt is. Almost every time a big loan (a bond) is sold in America, someone pays S&P for a rating. And every time money flows into an S&P 500 fund, S&P collects a tiny fee. Those are toll booths — it gets paid no matter who wins, and the fees keep coming year after year. It also sells financial data and software to Wall Street.
Is the stock cheap or expensive? Moderately priced, and cheaper than it's been. It usually trades at a rich price because the business is so good, but the stock has fallen about 22% from its high this past year, so you're getting a great company at a fairer price than usual. Our verdict is Buy — Tactical: worth owning, and the recent dip is the reason to look now, but don't expect it to double.
The one big worry: the debt-rating business only makes money when companies and governments are borrowing. In a year when borrowing dries up (a recession scare, or rates spiking), that most-profitable part of S&P slows down — which is exactly the kind of air-pocket that pushed the stock down this year.
Here's what our three scores mean in everyday terms:
Downside Risk 4/10 (fairly low). Rock-solid finances and steady cash flow, and it's already dropped, so a lot of bad news is priced in. It's not bulletproof — the price can still swing with the credit cycle.
Growth Quality 7/10 (good). A genuinely excellent, high-margin business — but it grows steadily in the high single digits, not explosively.
Exponential Potential 3/10 (low). It's already huge and mature. It compounds patiently; it will not multiply quickly.
Note on our confidence: no outside expert we track has published a view on this stock, so this write-up leans entirely on the numbers, not on anyone's conviction.
Solid = price · dashed = 50-day average · dotted = 200-day average · amber = 52-week high/low. Price above both averages is an uptrend.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Blue crossing above amber (bars flip green) = momentum turning up; below (bars red) = turning down. Bar height = the size of that gap.
Relative performance vs S&P 500 & its sector (XLF (sector)), set to 100 a year ago
Solid = SPGI · dashed = S&P 500 · dotted = XLF (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
Price$439.89
Market cap$130B
P/E trailing19×
P/E FY26E / FY27E24× / 21×
EV / Sales9.0×
EV / EBITDA17.5×
Gross margin70.5%
Net margin30.4%
Dividend yield0.88%
Beta1.076
52-wk range$374 – $564
RSI(14)69
50 / 200-DMA$411 / $461
12-mo return+-17% (SPY +21%)
Street target$548 ($482–$627)
Analyst grades24 Buy · 4 Hold · 0 Sell
FMP ratingB+
Next earnings2026-08-05
What the experts actually said 0 traceable claims on SPGI · showing the highest-conviction voices
Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.
1. What it is
S&P Global (NYSE: SPGI), founded 1860 and headquartered in New York, is a benchmarks-, data-, and analytics provider to the global capital, commodity and automotive markets. It runs through five reported divisions and is in the middle of reshaping the portfolio (a planned Mobility spin-off and the divestiture of an Upstream/Energy software portfolio). Fiscal year ends December 31. Current CEO: Martina Cheung.
Revenue mix — by segment (FY2025, from filings):
Market Intelligence $4.92B (32%) — multi-asset data, analytics and workflow for finance/corporate professionals.
Ratings $4.72B (31%) — the crown jewel: independent credit ratings; the highest-margin, most cyclical piece (tied to debt-issuance volumes).
Indices (S&P Dow Jones Indices) $1.85B (12%) — asset-light licensing on the S&P 500 and thousands of other benchmarks; scales with AUM in index products.
Mobility $1.75B (11%) — automotive data (being spun off).
(FY25 detail as tagged by FMP omits a discrete Energy/Commodity Insights line; in FY24 Commodity Insights was $2.14B. The five-segment total does not sum to consolidated revenue of $15.34B because of inter-segment eliminations and the Energy line not being separately tagged in the FY25 pull — treat the mix as directional.)
Revenue by geography (FY2025): United States $9.32B (~61%) · Europe $3.53B · Asia $1.64B · Rest of World $0.84B. US-concentrated but genuinely global; the non-US mix adds FX sensitivity (management flagged lower FX tailwinds in the FY26 outlook, §9).
The two structurally best businesses are Ratings (an entrenched duopoly with Moody's) and Indices (an asset-light licensing annuity on the S&P brand). Market Intelligence is more competitive (Bloomberg, FactSet, LSEG). The AI angle management keeps pushing: embedding generative-AI functionality across the data/analytics stack.
2. The expert thesis
There is no expert coverage of SPGI in the Synthos knowledge base.total_claims = 0; there are zero net-bullish (or bearish) voices to cite. Per house standard, we will not manufacture conviction we do not have: this verdict is fundamentals- and quant-driven only. Every judgment below is anchored to the FMP financials, the analyst-estimate set, management's own SEC-filed guidance (§9, half-weighted), and standard valuation work — not to any tracked expert claim.
That is a real limitation, and we flag it plainly: SPGI does not carry the breadth-of-conviction backing that our flagship-tier names do. If and when an expert voice in the KB takes a dated, traceable position, this note will be re-scored. Until then, treat the call as a quantitative quality-and-valuation read, sized accordingly (§12).
3. Synthos scores & the Bull / Base / Bear cases
Three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
Score
0–10
The read
Downside Risk(lower = safer)
4 · Low-Moderate
Net-debt/EBITDA 1.5×, beta 1.08, ~$5.5B FCF, dividend-aristocrat balance sheet — financially sturdy. But 28× trailing GAAP and a real −22% drawdown show the multiple de-rates when Ratings/FX tailwinds fade; Ratings' cyclicality is a structural flag.
Growth Quality
7 · Good
~11% forward adjusted-EPS CAGR, 70% gross / 44% EBIT / 30% net margins, ROIC ~10% / ROE ~15%, and a genuine toll-booth moat. Docked from "very high" because organic revenue is only mid-single-digit and Ratings' growth is cycle-dependent.
Exponential Potential
3 · Low
High-single-digit revenue, decelerating; a $130B mature oligopoly. Compounds durably, but there is no acceleration and limited room-to-run. A great business — not an exponential one.
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is the expected path, so a weighted blend would just restate it with false precision. The cases bound the range; the scores above summarize them.
Case
Key assumptions
Fair value
Bull
Debt-issuance stays robust, Indices AUM compounds, Mobility spin + AI monetization re-rate the stock. FY27E adj-EPS beats to ~$22.5 (vs ~$21.1 cons); multiple re-expands to a premium ~28×.
~$630 (+43%)
Base(our anchor)
Estimates roughly hit — FY27E adj-EPS ~$21.1; a high-quality mid-single-digit-organic compounder earns ~26×.
~$545 (+24%)
Bear
Issuance freeze / credit air-pocket hits Ratings, FX headwinds persist, Market Intelligence share erodes. FY27E adj-EPS misses to ~$18; multiple de-rates to ~20×.
~$360 (−18%)
Synthos fair value = the base case, ~$545 (+24%), with the full $360–$630 span as the honest range. This anchor essentially coincides with the Street's $548 consensus — we are not more constructive than the sell-side here; the quality is real but so is the mid-single-digit organic reality. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating multi-baggers-from-here). SPGI is a textbook durable compounder — and explicitly not an exponential:
Forward growth: revenue CAGR FY25→FY30E ~6.6% ($15.3B → $21.2B, 6 analysts); adjusted-EPS CAGR ~11% ($16.9 → $28.8) as buybacks and margin expansion lever the top line. Solid, not spectacular.
Acceleration (2nd derivative) is flat-to-negative: management guides FY26 organic constant-currency revenue +6.0% to +8.0% and reported +6.3% to +8.3% — squarely mid-single-digit, in line with (not above) the multi-year trend. There is no inflection to ride.
Room to run: at $130B market cap in mature end-markets (credit ratings, index licensing, financial data), the TAM is large but SPGI already holds oligopoly share of the best parts. A 3× from here implies a ~$390B company — plausible over a decade of compounding, but not the fast multibagger the "exponential" label requires.
Reinvestment runway: capex is tiny (~$0.2B/yr, ~1% of revenue) — the model is high-return but low-reinvestment; growth comes from pricing, M&A and buybacks, not a reinvestment flywheel. That caps the ceiling even as it protects the floor.
Exponential Potential: Low (3/10). Own SPGI for durable ~10% earnings compounding + a fortress moat, not for acceleration. This honest framing keeps it out of the Degen/next-exponential tier by design.
Earnings: FY25 GAAP net income $4.47B, diluted EPS $14.66; adjusted diluted EPS ran higher (~$16.9 per the estimate base). Q1'26 GAAP diluted EPS $4.69 (+32% YoY), adjusted $4.97 (+14%).
Cash flow: FY25 operating CF $5.65B, capex just −$0.20B, FCF ~$5.46B — a ~36% FCF/revenue conversion. Capital-light and cash-generative.
Balance sheet: total debt $14.2B, net debt $12.46B, net-debt/EBITDA 1.49×, interest coverage ~22×. Investment-grade and easily serviceable. Note: goodwill + intangibles are ~86% of assets (legacy of the 2022 IHS Markit deal) — book value is thin, tangible book is negative, which is normal for a serial acquirer of data assets but worth knowing.
6. Valuation — priced in or room?
SPGI is not statistically cheap, but it is cheaper than its own history and de-rated off the high. Trailing GAAP is 28× EPS; on adjusted forward earnings the multiple steps down cleanly: ~23× FY26E → ~21× FY27E → ~15× FY30E if estimates hit. EV/EBITDA is 17.5× and EV/sales 9.0× — rich in absolute terms but standard for a toll-booth data/index franchise (Moody's, the closest comp, trades similarly). Management's own FY26 guide is adjusted diluted EPS $19.40–$19.65, putting the stock at ~22.5× the midpoint of company guidance.
A reverse read: at ~$440 the market is paying ~21× FY27 adjusted earnings for a business compounding EPS ~11% with 44% EBIT margins and a wide moat — a fair-to-attractive price for the quality, especially after a 22% drawdown. Street targets (context): consensus $548, high $627, low $482 — our $545 base FV sits right on consensus. Not a screaming bargain; a quality-franchise-at-a-fairer-price buy, with the de-rating (not a growth acceleration) doing the work.
7. Technicals (from the tech block)
Trend:mixed / consolidating. $439.89 sits above the 50-DMA ($410.8) but below the 200-DMA ($460.6) — a recovering price still under its long-term average (the 50 below the 200 is a death-cross posture that is only just healing). MACD −1.23 (marginally negative).
Location:−22.0% off the 52-week high ($564.15), +17.7% off the 52-week low ($373.75). Max drawdown from peak −22% — a meaningful correction, now partly retraced.
Momentum: RSI(14) 69 — near-overbought (approaching 70) after the bounce, so the near-term entry is not pristine; a pause or pullback would be a lower-risk add.
Relative strength (the tell): SPGI −16.9% 12-mo vs SPY +20.6% and QQQ +30.3% — dramatic underperformance over the year, the source of the valuation reset. Shorter term it's stabilizing: +3.5% 3-mo (SPY +13.7%, QQQ +22.0%) still lags.
Read: technicals describe a de-rated quality name trying to base — attractive from a mean-reversion standpoint, but the RSI near 69 and price below the 200-DMA argue for scaling in rather than chasing. No confirmed uptrend yet.
8. Moat & competitive position
SPGI's moat is a rare double toll-booth: (1) Ratings — an entrenched duopoly with Moody's, protected by regulation (NRSRO status), issuer-pays economics, and a century of brand trust; issuers effectively must carry an S&P rating to access deep debt markets. (2) Indices — the S&P 500 and Dow Jones brands are effectively irreplaceable licensing annuities that scale with passive-investing AUM at ~zero incremental cost. Market Intelligence is the softer flank, competing head-on with Bloomberg, LSEG/Refinitiv and FactSet. The structural threats: Ratings' tie to debt-issuance cycles, potential regulatory pressure on issuer-pays, and data/analytics competition (including AI-native entrants) in Market Intelligence.
Peer set (FMP-supplied, market cap): the cleanest direct comp is Moody's (MCO) $85.7B — the other half of the ratings duopoly. The rest of the FMP peer list is a financials grab-bag rather than true comps: BlackRock $154.6B, Bank of America $416.8B, Capital One $126.4B, Toronto-Dominion $201.6B, Banco Santander $204.8B, Interactive Brokers $40.5B. Against MCO, SPGI is more diversified (Indices + Market Intelligence + Mobility) and trades at a broadly similar multiple; the diversification is a modest risk-reducer versus pure-play Moody's.
9. Management, capital allocation & guidance
Capital allocation: disciplined and shareholder-friendly. FY25 returned ~$5.0B via buybacks + $1.17B dividends; management now expects to return 100%+ of adjusted FCF to shareholders in 2026 (Q1'26 alone: $1B repurchased). Capex is negligible (~1% of revenue). The Mobility spin-off and Upstream-software divestiture are active portfolio-simplification moves aimed at unlocking value. Dividend is a long-standing aristocrat (quarterly $0.97 declared).
Insider activity (the tell): unusually, multiple insider purchases in the recent window — CEO Martina Cheung bought 2,322 shares at $429.93 (2026-04-29), a director (Moritz) bought at $434.03, and the S&P DJI CEO bought 2,500 shares at $431.39 (all around late-April 2026). Open-market buying by the CEO near current prices is a modestly bullish signal, not routine 10b5-1 selling.
Management's own guidance (half-weighted — their self-interested words): from the SEC 8-K (Q1'26 earnings release, filed 2026-04-28), management guides FY2026 reported revenue growth 6.3%–8.3%, organic constant-currency revenue growth 6.0%–8.0%, adjusted operating margin expansion 10–35 bps (50–75 bps ex-OSTTRA), tax rate 22.0%–23.0%, and adjusted diluted EPS $19.40–$19.65. They trimmed reported-revenue guidance ~30 bps on lower FX tailwinds while holding organic guidance. GAAP guidance beyond revenue/capex is withheld pending the Mobility spin. CEO Cheung cited "strong revenue growth and margin expansion in every division" and "fast-paced adoption of our AI functionality." Treat as management's own book: directionally credible, half-weighted.
10. Catalysts & what to watch
Next earnings: 2026-07-30 (Q2'26; Street adj-EPS $4.92, revenue ~$4.08B). Key line: Ratings revenue and debt-issuance commentary (the cyclical swing factor).
Mobility spin-off: completion, terms, and the updated ex-Mobility guidance / GAAP guidance reinstatement — a value-unlock and re-rating catalyst.
Debt-issuance environment: high-yield/investment-grade issuance volumes drive the highest-margin segment; a rate-cut cycle that revives issuance is a tailwind, a credit freeze is the bear case.
Indices AUM & passive flows: continued index-product inflows compound the annuity.
AI monetization: whether embedded generative-AI features convert to pricing/retention in Market Intelligence (the competitive flank).
Thesis tripwires (what would change the call): two consecutive quarters of Ratings-revenue decline on frozen issuance; organic revenue slipping below mid-single-digits; adjusted operating margin contracting; or a Mobility spin that destroys rather than unlocks value.
11. Key risks
Ratings cyclicality (structural, the #1 risk): the highest-margin segment is tied to debt-issuance volumes — a credit crunch or issuance freeze compresses it fast. This is the single biggest swing factor and the likely cause of the 12-month de-rating.
Valuation / de-rating: 28× trailing leaves room to fall further if growth or margins disappoint; the −22% drawdown shows the multiple is not bulletproof.
FX headwinds: ~39% non-US revenue; management already trimmed reported-revenue guidance on weaker FX tailwinds.
Competitive pressure in Market Intelligence: Bloomberg, LSEG and FactSet (plus AI-native entrants) contest the softest, most competitive segment.
Regulatory / issuer-pays scrutiny: the Ratings business's economics are perennially exposed to regulatory attention.
Execution / integration: heavy goodwill+intangibles (~86% of assets) and a Mobility spin in flight create execution and stranded-cost risk.
Conviction gap (house-specific): zero expert coverage in the Synthos KB — this call carries less independent validation than our flagship names.
12. Verdict, position sizing & monitoring
Buy — Tactical. SPGI is one of the highest-quality franchises in the index — a double toll-booth (Ratings + Indices) with 44% EBIT margins, ~$5.5B FCF, a fortress balance sheet, insider buying, and a Mobility spin that could unlock value. It has de-rated ~22% off its high on cooling debt-issuance and FX tailwinds, resetting the multiple to a fairer ~21–23× forward adjusted EPS. That combination — great business, cyclically pressured price — is the reason to look now. But the growth is mid-single-digit organic and decelerating, the KB gives us zero expert conviction, and the near-term technicals (below the 200-DMA, RSI near 69) aren't pristine — so this is a tactical quality-on-weakness buy, not a high-conviction core overweight.
Sizing:~2–4% if bought — a quality holding sized for moderate conviction (no expert breadth behind it). Scale in on weakness rather than chasing the bounce; a pullback toward the rising 50-DMA (~$411) would be a lower-risk add.
Monitoring: re-underwrite on the §10 tripwires; formal re-score each earnings print and on the Mobility spin. This verdict is logged as a tracked Synthos call as of 2026-07-03 at $439.89.
Single biggest risk: Ratings' tie to debt-issuance volumes — a credit/issuance freeze compresses the crown-jewel segment.
Provenance & disclosures
Traceability:0 KB claims — SPGI has no expert coverage in the Synthos knowledge base. The verdict is explicitly fundamentals-, valuation- and quant-driven; no conviction is claimed or fabricated.
Data as-of: fundamentals 2026-03-31 (Q1'26) · estimates & prices 2026-07-02/03 · no expert claims. Forward figures are analyst consensus (FMP) or management guidance, labeled as estimates.
Management caveat: the FY2026 guidance in §9 is management's own SEC-filed outlook (8-K, 2026-04-28), half-weighted by design as a self-interested source.
Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").